{
    "paper_id": "PMC5714810",
    "metadata": {
        "title": "Enterovirus genotypes among patients with severe acute respiratory illness, influenza\u2010like illness, and asymptomatic individuals in South Africa, 2012\u20102014",
        "authors": [
            {
                "first": "Orienka",
                "middle": [],
                "last": "Hellferscee",
                "suffix": "",
                "email": "orienkah@nicd.ac.za",
                "affiliation": {}
            },
            {
                "first": "Stefano",
                "middle": [],
                "last": "Tempia",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Sibongile",
                "middle": [],
                "last": "Walaza",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Ebrahim",
                "middle": [],
                "last": "Variava",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Halima",
                "middle": [],
                "last": "Dawood",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Nicole",
                "middle": [],
                "last": "Wolter",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Shabir",
                "middle": [
                    "A."
                ],
                "last": "Madhi",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Mignon",
                "middle": [],
                "last": "du Plessis",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Cheryl",
                "middle": [],
                "last": "Cohen",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Florette",
                "middle": [
                    "K."
                ],
                "last": "Treurnicht",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Pneumonia is the leading cause of death in children globally and is the most common reason for hospitalization among African children.1, 2 Respiratory viruses associated with acute respiratory tract infections include influenza virus A and B, respiratory syncytial virus, parainfluenza virus types 1, 2, and 3, adenovirus and human metapneumovirus. Other respiratory viruses putatively associated with pneumonia in children also include enteroviruses, rhinovirus, human bocavirus, and human coronaviruses (229E, NL63, OC43, HKU1), although this remains controversial.3, 4 Although influenza and respiratory syncytial viruses have been well described as causes of pneumonia in South Africa, little is known about enterovirus prevalence and circulating genotypes.5, 6\n",
            "cite_spans": [],
            "section": "INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "Enteroviruses are members of the enterovirus genus in the family Picornaviridae.7 The capsid protein VP1, the most variable protein containing the majority of neutralization epitopes, is commonly used to characterize enteroviruses.7, 8, 9 More than 100 enterovirus genotypes are currently classified into four species, HEV\u2010A, HEV\u2010B, HEV\u2010C, HEV\u2010D, which have different pathogenic profiles and circulation patterns.7, 10\n",
            "cite_spans": [],
            "section": "INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "Enteroviruses (EV) can cause symptoms similar to a mild cold, but have also been associated with severe respiratory infection requiring hospitalisation and may be fatal.10 An outbreak of a re\u2010emerging EV\u2010D68 lineage causing severe acute respiratory illness (SARI) occurred in the USA and Canada in 2014, and these lineages were also detected in Europe, Asia, and South America from 2012 to 2013 samples.11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 Though EVs have been associated with SARI and influenza\u2010like illness (ILI),5 these viruses have been less well characterized in South Africa. We identified high diversity among EVs circulating in hospitalized South African patients,25 however it is unknown whether different EV genotypes are associated with mild or severe respiratory illness in South Africa.",
            "cite_spans": [],
            "section": "INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "We aimed to characterize the EV genotypes circulating among South African patients with SARI, ILI, and asymptomatic individuals from June 2012 to July 2014. In addition we assessed the association of different EV species with mild (ILI) or severe (SARI) illness compared to asymptomatic individuals.",
            "cite_spans": [],
            "section": "INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "We conducted prospective, hospital\u2010based, SARI surveillance from June 2012 to July 2014 at two sites (Klerksdorp\u2010Tshepong Hospital Complex, Klerksdorp, North West Province, and Edendale Hospital, Pietermaritzburg, KwaZulu\u2010Natal Province) in South Africa.",
            "cite_spans": [],
            "section": "Severe acute respiratory illness (SARI) surveillance ::: Study population and setting ::: METHODS",
            "ref_spans": []
        },
        {
            "text": "A case of SARI was defined as a hospitalized individual with duration of symptoms \u226410 days, meeting age\u2010specific clinical inclusion criteria as follows: children aged 2 days through <3 months with physician\u2010diagnosed sepsis or lower respiratory tract infection (LRTI), children aged 3 months through <5 years with physician\u2010diagnosed LRTI and patients aged \u22655 years meeting a modified World Health Organization (WHO) case definition for SARI: (i) fever (>38\u00b0C) or reported fever; (ii) cough or sore throat; and (iii) shortness of breath, or difficulty breathing, with or without clinical or radiographic findings of pneumonia. Demographic and clinical characteristics were collected from all patients.",
            "cite_spans": [],
            "section": "Severe acute respiratory illness (SARI) surveillance ::: Study population and setting ::: METHODS",
            "ref_spans": []
        },
        {
            "text": "Prospective surveillance for cases presenting with ILI were done at two outpatient clinics (Jouberton Clinic, North West Province, and Edendale Gateway Clinic, KwaZulu\u2010Natal Province) located in the same catchment area to the above\u2010mentioned hospitals from July 2012 through June 2014. An ILI case was defined as an outpatient of any age presenting with either temperature >38\u00b0C or, history of fever and cough of duration \u226410 days.5\n",
            "cite_spans": [],
            "section": "Influenza\u2010like illness (ILI) surveillance ::: Study population and setting ::: METHODS",
            "ref_spans": []
        },
        {
            "text": "An asymptomatic individual or control was defined as a person presenting at the same outpatient clinics with no history of fever, respiratory, or gastrointestinal symptoms during the 14 days preceding the visit. These individuals commonly presented to the clinics for visits such as dental procedures, family planning, well baby visits, voluntary HIV counseling and testing, or acute care for non\u2010febrile illnesses. We aimed to enroll one HIV\u2010infected and one HIV\u2010uninfected control every week in each clinic within each of the following age categories: 0\u20101, 2\u20104, 5\u201014, 15\u201054, and \u226555 years. Individuals were not followed\u2010up to ensure they remained asymptomatic after enrollment.",
            "cite_spans": [],
            "section": "Asymptomatic individuals ::: Study population and setting ::: METHODS",
            "ref_spans": []
        },
        {
            "text": "Study staff completed case report forms for all enrolled SARI and ILI cases as well as controls. In addition, for SARI cases, hospital records were reviewed to assess disease progression and outcome (ie, discharge, transfer, or in\u2010hospital death). Referral to hospital was recorded for all enrolled ILI cases. ILI cases that were referred to hospital were excluded from the analysis, as these patients did not adhere to the case definition of ILI anymore.",
            "cite_spans": [],
            "section": "Study procedures ::: Study population and setting ::: METHODS",
            "ref_spans": []
        },
        {
            "text": "HIV results were obtained from a combination of two sources: (i) patient clinical records when available and (ii) for consenting patients, an anonymized linked dried blood spot was tested at the National Institute for Communicable Diseases (NICD). When both results were available, the NICD result was used.",
            "cite_spans": [],
            "section": "Determination of HIV status ::: Study population and setting ::: METHODS",
            "ref_spans": []
        },
        {
            "text": "Nasopharyngeal aspirates for children <5 years of age and nasopharyngeal and oropharyngeal swabs from persons \u22655 years of age were collected from all enrolled participants and placed in universal transport medium (Copan, Murruieta, CA).",
            "cite_spans": [],
            "section": "Samples and laboratory procedures ::: METHODS",
            "ref_spans": []
        },
        {
            "text": "All respiratory tract specimens were tested for the presence of 10 respiratory viruses (influenza virus A and B, respiratory syncytial virus, parainfluenza virus types 1, 2, and 3, adenovirus, human metapneumovirus, and rhinovirus) including EV, using a multiplex real\u2010time reverse transcriptase polymerase chain reaction assay.26 The real\u2010time reverse transpriptase polymerase chain reaction used for EV testing, is a sensitive method for the routine detection of all members of the enterovirus genus. This method has a weak cross\u2010reactivity to high\u2010titre rhinovirus stocks, but not with rhinovirus\u2010positive clinical samples.27\n",
            "cite_spans": [],
            "section": "Samples and laboratory procedures ::: METHODS",
            "ref_spans": []
        },
        {
            "text": "All specimens testing positive for enterovirus were selected for molecular characterization. A 400 base pair region of the VP1 gene was amplified and sequenced as previously described using primer set 224/222 during the first round of amplification and primer set AN89/AN88 for the nested amplification.8 This assay was originally designed to detect and identify EV, but also detects and identifies a subset of rhinoviruses.",
            "cite_spans": [],
            "section": "Amplification and sequencing of enterovirus VP1 gene ::: METHODS",
            "ref_spans": []
        },
        {
            "text": "Amplicons were purified using the ExoSAP enzyme system (Thermo Fisher Scientific, Waltham, MA) and sequenced using the Big\u2010Dye Terminator version 3.1 Cycle Sequencing Ready Reaction kit (Life Technologies, Carlsbad, CA) using nested primers. Sequencing reactions were purified with the BigDye\u00ae XTerminator Purification kit (Life Technologies, Carlsbad, CA) and resolved on the 3130XL Genetic Analyzer (Life Technologies, Carlsbad, CA). Sequences were analyzed and assembled using Sequencher\u00ae version 5 (Gene Codes Corporation, Ann Arbor, MI).",
            "cite_spans": [],
            "section": "Amplification and sequencing of enterovirus VP1 gene ::: METHODS",
            "ref_spans": []
        },
        {
            "text": "The genetic diversity of each VP1 sequence was first determined by comparison with the reference strains in GenBank (US National Center for Biotechnology Information, NCBI, http://www.ncbi.nlm.nih.gov/, accessed 01 July 2016) using BLAST (Basic Local Alignment Search Tool) and confirmed by phylogenetic analysis of the partial VP1 sequences. Multiple sequence alignments were generated in the MAFFT (Multiple Alignment using Fast Fourier Transform) multiple sequence alignment program28 and analyzed in the BioEdit Sequence Alignment Editor Software.29 Phylogenetic trees were generated using the neighbor\u2010joining method and genetic distances were calculated with the Kimura\u20102\u2010parameter model using MEGA (Molecular Evolutionary Genetics Analysis) 6 software.30\n",
            "cite_spans": [],
            "section": "Phylogenetic analysis ::: METHODS",
            "ref_spans": []
        },
        {
            "text": "The statistical significance of the phylogenies was estimated by bootstrap analysis using 1000 pseudo replicates. Sub analysis was similarly done for the three dominant EV species in this study. Sequences of enterovirus partial VP1 genes generated in this study have been deposited in GenBank with the following accession numbers: KX940982\u2010KX941096.",
            "cite_spans": [],
            "section": "Phylogenetic analysis ::: METHODS",
            "ref_spans": []
        },
        {
            "text": "The Chi\u2010squared or Fisher's exact test were used for comparison of categorical variables. Unconditional exact logistic regression was used to assess the association of EV species with disease severity among patients with mild (ILI) or severe illness (SARI) using asymptomatic individuals as control group. Exact logistic regression was used to account for the fact that no EV\u2010D species was detected among controls. EV\u2010B was used as the comparison group as it was the species most frequently detected. Significance was assessed for P < 0.05. All models were adjusted for age, HIV serostatus and underlying medical conditions. The analysis was performed using STATA 14.1 (StataCorp, College Station, TX).",
            "cite_spans": [],
            "section": "Statistical analysis ::: METHODS",
            "ref_spans": []
        },
        {
            "text": "The SARI protocol was approved by the University of the Witwatersrand Human Research Ethics Committee (HREC) and the University of KwaZulu\u2010Natal Human Biomedical Research Ethics Committee (BREC), protocol numbers M081042 and BF157/08, respectively. The ILI and control protocol was approved by HREC and BREC protocol numbers M120133 and BF080/12, respectively. This surveillance was deemed non\u2010research by the US Centers for Disease Control and Prevention.",
            "cite_spans": [],
            "section": "Ethical approval ::: METHODS",
            "ref_spans": []
        },
        {
            "text": "During the study period we enrolled 1525 patients with SARI, 3088 with ILI, and 1401 controls, of which 1494 (97.60%), 3079 (99.7%), and 1367 (97.6%) were tested and had EV results available, respectively. The detection rate for enterovirus was 5.8% (87/1494), 3.4% (103/3079), and 3.4% (46/1367) among SARI, ILI, and controls, respectively (SARI/controls, P = 0.002 and ILI/control, P = 0.973). In children <1 year of age, the majority (61.1%, 44/72) of EV positive samples presented with SARI while in the following age groups: 1\u20104 years (43.1%, 50/116), 5\u201018 years (53.9%, 14/26), and >18 years (81.8%, 18/22) the majority of patients presented with ILI (P < 0.001). Among EV positive samples stratified in age groups above, HIV infection was not significant in any of the cases or controls (data not shown). We observed that among EV\u2010positive SARI cases with documented disease progression and outcome, 3.9% (2/51) were admitted to ICU and 2% (1/50) died however the causal role of EV infection in adverse outcomes could not be addressed in this study.",
            "cite_spans": [],
            "section": "SARI epidemiology of the study population ::: RESULTS",
            "ref_spans": []
        },
        {
            "text": "EV was detected throughout the year among SARI and ILI cases and controls (Fig. 1A\u2010C), with peaks above 10% from the detection rate during February\u2010March, August and November.",
            "cite_spans": [],
            "section": "SARI epidemiology of the study population ::: RESULTS",
            "ref_spans": [
                {
                    "start": 80,
                    "end": 81,
                    "mention": "1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "Of the 236 EV\u2010positive specimens detected during the study period among SARI and ILI cases and controls, 30.1% (71/236) were excluded from VP1 RT\u2010PCR attempts, since the EV load in these samples was considered low (Ct\u2010value >35) and the attempt has a higher probability of failure. An additional 16.5% (39/236) of samples were excluded from VP1 RT\u2010PCR and sequencing attempts, because the original specimen volume was insufficient for RNA extraction. Of the EV\u2010positive samples that were sequenced (53.4%, 126/236), 7.9% (10/126) could not be typed. Possible reasons for typing failure included failed sequencing reactions, mixed EV infections (co\u2010infections) and RV that was detected on the initial EV screen real\u2010time PCR assay. RV were identified in 11.9% (15/126) samples, and were excluded from the EV phylogenetic analysis. Therefore, only 101 EV\u2010positive samples were used for subsequent phylogenetic comparison.",
            "cite_spans": [],
            "section": "Phylogenetic comparison of EV genotypes identified during June 2012\u2010July 2014 ::: RESULTS",
            "ref_spans": []
        },
        {
            "text": "Neighbor\u2010joining phylogenetic comparison of EVs detected in clinical samples from June 2012 to July 2014 to international reference sequences indicated that EV\u2010B (60.4%; 61/101) and EV\u2010A (21.8%; 22/101) were more commonly identified than EV\u2010C (10.9%; 11/101) and EV\u2010D (6.9%; 7/101) (Supplementary Fig. S1). The majority of EV\u2010A (40.9%, 9/22) and EV\u2010D (57.1%, 4/7) were detected among ILI cases and the majority of EV\u2010B (55.7%, 34/61) and EV\u2010C (54.6%, 6/11) were detected among SARI cases (P = 0.03).",
            "cite_spans": [],
            "section": "Phylogenetic comparison of EV genotypes identified during June 2012\u2010July 2014 ::: RESULTS",
            "ref_spans": []
        },
        {
            "text": "On multivariable logistic regression analysis using EV species B as the reference group and controlling for age, HIV status and underlying illness, no association with disease severity (SARI or ILI compared to controls) was identified for any of the EV species (Supplementary Table S1).",
            "cite_spans": [],
            "section": "Phylogenetic comparison of EV genotypes identified during June 2012\u2010July 2014 ::: RESULTS",
            "ref_spans": []
        },
        {
            "text": "Enterovirus genotypes could be identified in 59% (51/87), 33% (34/103), and 35% (16/46) of enterovirus\u2010positive samples among SARI and ILI cases and controls, respectively. We identified a total of 33 genotypes, distributed among all four EV species. The most prevalent genotype was E30 (9.9%, 10/101), followed by CVB5 (7.9%, 8/101) and EV\u2010D68 (6.9%, 7/101). All other genotypes identified in the study were detected in <5% of genotyped samples (Supplementary Fig. S2).",
            "cite_spans": [],
            "section": "EV group and genotypes ::: RESULTS",
            "ref_spans": []
        },
        {
            "text": "Coxsackievirus A14 (CVA14), Echovirus 11 (E11), Echovirus 16 (E16), Echovirus 17 (E17), Echovirus 19 (E19), Echovirus 7 (E7), Echovirus 9 (E9), poliovirus 1 (Sabin vaccine strain), poliovirus 3 (Sabin vaccine strain) were detected only among SARI cases and Coxsackievirus A10 (CVA10), Coxsackievirus A16 (CVA16), Coxsackievirus B1 (CVB1), Echovirus 32 (E32), and Coxsackievirus A20 (CVA20) were detected only among ILI cases. CVB5, E30, Echovirus 6 (E6) and EV\u2010D68 were detected among SARI and ILI cases only (Supplementary Fig. S2).",
            "cite_spans": [],
            "section": "EV group and genotypes ::: RESULTS",
            "ref_spans": []
        },
        {
            "text": "EV\u2010A, EV\u2010B, EV\u2010C, and EV\u2010D genotypes co\u2010circulated in 2012\u20102014, while EV\u2010D68 was detected sporadically in March\u2010May in 2013 and 2014 only (Fig. 2). The majority of EV positive samples that could be genotyped, were from children aged <5 years (89.1%, 90/101) in the EV\u2010B species (60.4%, 61/101) compared to the other EV species, but were not statistically significant (P = 0.08).",
            "cite_spans": [],
            "section": "EV group and genotypes ::: RESULTS",
            "ref_spans": [
                {
                    "start": 145,
                    "end": 146,
                    "mention": "2",
                    "ref_id": "FIGREF1"
                }
            ]
        },
        {
            "text": "Phylogenetic analysis of E30 samples showed that all E30 samples from this study clustered with a single Australian strain from 2000 (GU232849) with 98% bootstrap support. Following the classification convention for E30 as described by Bailly et al,31 we propose to call this sub cluster genotype k. The nucleotide sequences for E30 strains were downloaded from GenBank and sequences depicted in Fig. 3 represent all known genotypes.",
            "cite_spans": [],
            "section": "E30 ::: Molecular evolution of E30, CVB5, and EV\u2010D68 genotypes ::: RESULTS",
            "ref_spans": [
                {
                    "start": 401,
                    "end": 402,
                    "mention": "3",
                    "ref_id": "FIGREF2"
                }
            ]
        },
        {
            "text": "All E30 strains identified in this study displayed >98% nucleotide (nt) homology and formed a distinct bi\u2010phyletic cluster with 79% bootstrap support (Fig. 3). In the bi\u2010phyletic cluster, strains from Edendale SARI cases and Klerksdorp SARI and ILI cases are distinctly located in each of the sub clusters with 92% bootstrap support, respectively.",
            "cite_spans": [],
            "section": "E30 ::: Molecular evolution of E30, CVB5, and EV\u2010D68 genotypes ::: RESULTS",
            "ref_spans": [
                {
                    "start": 156,
                    "end": 157,
                    "mention": "3",
                    "ref_id": "FIGREF2"
                }
            ]
        },
        {
            "text": "The E30 strains in our study differ from other E30 genotypes by mean nucleotide pairwise distance of 20.2% (15.6\u201027.5) and mean amino acid sequence distance of 6% (2.7\u201011.6) in amino acid sequence.",
            "cite_spans": [],
            "section": "E30 ::: Molecular evolution of E30, CVB5, and EV\u2010D68 genotypes ::: RESULTS",
            "ref_spans": []
        },
        {
            "text": "All CVB5 strains identified in our study (six SARI samples and two ILI samples from Edendale) were categorized as genogroup C and formed a distinct sub cluster with a bootstrap value of 91% (Fig. 4). The nucleotide sequences for CVB5 strains were downloaded from GenBank and sequences depicted in Fig. 4 represent all known genogroups.",
            "cite_spans": [],
            "section": "CVB5 ::: Molecular evolution of E30, CVB5, and EV\u2010D68 genotypes ::: RESULTS",
            "ref_spans": [
                {
                    "start": 196,
                    "end": 197,
                    "mention": "4",
                    "ref_id": "FIGREF3"
                },
                {
                    "start": 302,
                    "end": 303,
                    "mention": "4",
                    "ref_id": "FIGREF3"
                }
            ]
        },
        {
            "text": "6/8 samples (four SARI and two ILI samples) were identical (nt homology 100%). All of our CVB5 strains (identified in this study) displayed close genetic relationships with samples identified in surface water from Belarus, 2007 (GQ352398) and feces from Germany, 2009 (HF948277).",
            "cite_spans": [],
            "section": "CVB5 ::: Molecular evolution of E30, CVB5, and EV\u2010D68 genotypes ::: RESULTS",
            "ref_spans": []
        },
        {
            "text": "Sequences from the South African CVB5 strains differed from the other CVB5 genogroup C sequences by 13.4% in pairwise nucleotide sequence distance and 3% in pairwise amino acid sequence. Samples SA 502662 and SA 502658 which were not identical to the other South African sequences were sampled in 2012 and 2013, respectively.",
            "cite_spans": [],
            "section": "CVB5 ::: Molecular evolution of E30, CVB5, and EV\u2010D68 genotypes ::: RESULTS",
            "ref_spans": []
        },
        {
            "text": "The majority (71.4%, 5/7) of EV\u2010D68 strains identified in 2013/2014 distinctly clustered in lineage B2 (89% bootstrap support) of which three were ILI cases and two were SARI cases, together with strains from one of the two co\u2010circulating EV\u2010D68 lineages that caused the large 2014 USA outbreak (Fig. 5). The nucleotide sequences for EVD\u201068 strains were downloaded from GenBank and sequences depicted in Fig. 5 represent all known lineages.",
            "cite_spans": [],
            "section": "EV\u2010D68 ::: Molecular evolution of E30, CVB5, and EV\u2010D68 genotypes ::: RESULTS",
            "ref_spans": [
                {
                    "start": 301,
                    "end": 302,
                    "mention": "5",
                    "ref_id": "FIGREF4"
                },
                {
                    "start": 409,
                    "end": 410,
                    "mention": "5",
                    "ref_id": "FIGREF4"
                }
            ]
        },
        {
            "text": "The lineage B EV\u2010D68 strains in our study differed from other lineage B EV\u2010D68 strains by 1.5% nucleotide and 1.4% amino acid sequence. These included two SARI cases (one from Klerksdorp and one from Edendale) and three ILI cases (one from Klerksdorp and two from Edendale).",
            "cite_spans": [],
            "section": "EV\u2010D68 ::: Molecular evolution of E30, CVB5, and EV\u2010D68 genotypes ::: RESULTS",
            "ref_spans": []
        },
        {
            "text": "The other South African EV\u2010D68 strains (28.6%, 2/7) belonged to lineage A forming a unique cluster. The two strains from 2013 are from the same geographic location and clustered with 99% bootstrap support. The lineage A EV\u2010D68 strains in our study differed from other lineage A EV\u2010D68 strains by 12.8% nucleotide and 3.0% amino acid sequence. The 2012\u20102014 South African samples did not cluster with EV\u2010D68 samples previously identified in South African patients.25, 32\n",
            "cite_spans": [],
            "section": "EV\u2010D68 ::: Molecular evolution of E30, CVB5, and EV\u2010D68 genotypes ::: RESULTS",
            "ref_spans": []
        },
        {
            "text": "We describe the EV species circulating among SARI and ILI cases and asymptomatic controls in South Africa. We observed a high diversity of circulating EV genotypes (a total of 33 genotypes) from EV species A\u2010D with high circulation rates for EV\u2010B and EV\u2010A compared to EV\u2010C and EV\u2010D.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "From our systematic surveillance across all age groups, the majority of patients testing positive for EV were <5 years of age. We did not observe any difference in disease association due to different EV species since EV disease association cannot be conclusively ascribed since the analysis did not include co\u2010infections with other pathogens. Epidemics of human EV disease display a seasonal pattern, with infections more common in summer and early autumn in geographical regions with a temperate climate.7, 33 Most clusters of EV\u2010D68 showed an atypical late seasonality compared to other EVs, with a peak in autumn, instead of summer.7 Outbreaks of EV disease in autumn, early or late, are typical. Distribution of EV\u2010A through \u2010D in most temperate zones is from spring through autumn, with peak disease in most years in late summer\u2010autumn. This study showed similarities in the seasonal distribution of the EV species detected in South Africa as EV species A\u2010D were detected throughout the year, but EV\u2010D68 was sporadically detected in autumn (March\u2010May) during 2013\u20102014.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "E30, CVB\u20105, and EV\u2010D68 were the genotypes most frequently identified in this study. Within a genotype, EVs are deemed relatively uniform, as was observed in our study for E30 and CVB5. However, some studies have suggested variation within a genotype,34 such as was observed for EV\u2010D68 in our study.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "E30 is the most common EV strain responsible for sporadic as well as large\u2010scale outbreaks of aseptic meningitis in many countries of Europe and North America.31 E30 causes large outbreaks of aseptic meningitis that attracts public health attention and as a result there is a rich and large database of E30 VP1 sequences regarding aseptic meningitis, E30 has however not been associated with respiratory illness.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "A common feature of E30 molecular epidemiology is the progression of circulating lineages within one prevalent genotype.9, 31 The E30 strains identified in this study clustered together (designated genotype k) although no differences were observed between viruses from SARI compared to ILI cases. There is no report of a concurrent E30 aseptic meningitis outbreak at the same time the E30 NP/OP positives were detected. It has been reported that genotypes of E30 can become dominant for 3\u20104\u2010year periods before they disappear from circulation,34 and they are therefore known as epidemic strains. In our study, it seems that E30 genotype k became dominant and circulated in South Africa during 2012\u20102014. Phylogenetic studies with VP1 sequences indicate that E30 variants are continuously emerging and replacing the circulating E30 strains, largely due to the error prone EV RNA polymerase31.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "CVB5 has been detected for over 50 years and, similar to E30, sporadic cases of aseptic meningitis, as well as outbreaks, have been reported, remaining one of the most predominant reported EV genotypes in a number of countries.35 All of the CVB5 strains identified in this study formed a sub cluster in genogroup C. Phylogenetic clustering by year of study enrolment was observed for the South African strains. Different co\u2010circulating strains of EV are often observed in EV disease outbreaks as EV genomes vary with respect to time but may also vary by geographical distribution.36\n",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "In 2014, the largest outbreak to date of severe respiratory illness associated with EV\u2010D68 occurred in the USA, and almost all of the case patients were children.37 Coinciding with the 2014 USA outbreak there was an increased number of reports of children with sudden onset acute flaccid myelitis (AFM). Some recent South African EV\u2010D68 strains clustered with USA 2014 lineage B2 EV\u2010D68 strains. The USA 2014 lineage B2 co\u2010circulated with lineage B1 EV\u2010D68 during the large 2014 USA outbreak. EV\u2010D68 lineages B1 and B2 are both temporally associated with AFM.38 The majority of EV\u2010D68 strains identified in our study clustered in lineage B2 and the remaining samples clustered in lineage A, forming a unique cluster. The 2012\u20102014 South African samples did not cluster with strains previously identified in South Africa during 2009\u20102011.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "The mechanisms for emergence of EV\u2010associated outbreaks are not known; however, a combination of virus\u2010specific, population\u2010level, and other external factors are likely to be involved.7\n",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "Our study has some limitations. Previous studies observed a difference in the predominant EV genotypes among neonates and older children39 but we were not powered for this analysis. Some rhinovirus sequences were detected in samples that tested positive for EV on our in\u2010house assay indicating that our EV detection assay is not 100% specific to detect only EVs. This study was not designed to describe the role of co\u2010infections with other respiratory pathogens. In addition the association with EV detection with mild and severe illness was not investigated.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "In conclusion, we showed that there was a high diversity in the VP1 sequences of the EV species circulating in South Africa during 2012\u20102014 and most of these genotypes are associated with meningitis worldwide. EV was detected in outpatient and hospitalized patients with SARI but was also detected in controls. We determined no disease association of EV species with disease severity; however, some genotypes (E30, CVB5, EV\u2010D68) were more prevalent in symptomatic cases. Further studies are needed to determine if other factors such as viral load or host interactions play a role in EV\u2010associated disease as well as a robust spatiotemporal phylogenetic analysis based on complete VP1 sequences.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "FIGREF0": {
            "text": "Figure 1: Monthly number and overall detection rate of enterovirus (EV)\u2010positive cases among controls (A), influenza\u2010like illness (B), and severe acute respiratory patients (C), Klerksdorp and Pietermaritzburg, South Africa, 2012\u20132014",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Figure 2: Distribution of enterovirus (EV) species (A\u2010D) in South Africa during June 2012 to July 2014 (dnt = did not genotype)",
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Figure 3: Phylogenetic analysis of E30 serotypes by neighbor\u2010joining phylogenetic analysis of the partial VP1 region, South Africa, 2012\u20102014. Sequences with black closed circles denote serotypes identified in SARI patients and those with grey closed circles denote serotypes identified in ILI patients. Bootstrap values (1000 replicates) are shown on the branches, with values <65% omitted from the tree. The scale indicates number of base substitutions per site",
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Figure 4: Phylogenetic analysis of CVB5 genogroups by neighbor\u2010joining phylogenetic analysis of the partial VP1 region, South Africa, 2012\u20102014. Sequences with black closed circles denote serotypes identified in SARI patients and those with grey closed circles denote genotypes identified in ILI patients. Bootstrap values (1000 replicates) are shown on the branches, with values <65% omitted from the tree. The scale indicates number of base substitutions per site",
            "type": "figure"
        },
        "FIGREF4": {
            "text": "Figure 5: Phylogenetic analysis of EV\u2010D68 lineages by neighbor\u2010joining phylogenetic analysis of the partial VP1 region, South Africa, 2012\u20102014. Sequences with black closed circles denote serotypes identified in SARI patients and those with grey closed circles denote serotypes identified in ILI patients. Sequences with open circles are EV\u2010D68 strains previously identified from South Africa. Bootstrap values (1000 replicates) are shown on the branches, with values <65% omitted from the tree. The scale indicates number of base substitutions per site",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Childhood pneumonia\u2014progress and challenges",
            "authors": [],
            "year": 2006,
            "venue": "S Afr Med J",
            "volume": "96",
            "issn": "",
            "pages": "890-\u2013900",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "",
            "authors": [],
            "year": 2015,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Development and implementation of a molecular diagnostic platform for daily rapid detection of 15 respiratory viruses",
            "authors": [],
            "year": 2009,
            "venue": "J Med Virol",
            "volume": "81",
            "issn": "",
            "pages": "167-175",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Multiplex real\u2010time PCR for detection of respiratory tract infections",
            "authors": [],
            "year": 2008,
            "venue": "J Clin Virol",
            "volume": "41",
            "issn": "",
            "pages": "53-56",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "The role of influenza, RSV and other common respiratory viruses in severe acute respiratory infections and influenza\u2010like illness in a population with a high HIV sero\u2010prevalence, South Africa 2012\u20132015",
            "authors": [],
            "year": 2016,
            "venue": "J Clin Virol",
            "volume": "75",
            "issn": "",
            "pages": "21-26",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Epidemiology of influenza virus types and subtypes in South Africa, 2009\u20102012",
            "authors": [],
            "year": 2014,
            "venue": "Emerg Infect Dis",
            "volume": "20",
            "issn": "",
            "pages": "1149-1156",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "The epidemiology of non\u2010polio enteroviruses",
            "authors": [],
            "year": 2015,
            "venue": "Curr Opin Infect Dis",
            "volume": "28",
            "issn": "",
            "pages": "479-487",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens",
            "authors": [],
            "year": 2006,
            "venue": "J Clin Microbiol",
            "volume": "44",
            "issn": "",
            "pages": "2698-2704",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "Typing of human enteroviruses by partial sequencing ofVP1",
            "authors": [],
            "year": 1999,
            "venue": "J Clin Microbiol",
            "volume": "37",
            "issn": "",
            "pages": "1288-1293",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Picornavirus and enterovirus diversity with associated human diseases",
            "authors": [],
            "year": 2013,
            "venue": "Infect Genet Evol",
            "volume": "14",
            "issn": "",
            "pages": "282-\u2013293",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "Molecular and epidemiological study of enterovirus D68 in Taiwan",
            "authors": [],
            "year": 2015,
            "venue": "J Microbiol Immunol Infect",
            "volume": "10",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "Coexistence of two clades of enterovirus D68 in pediatric Swedish patients in the summer and fall of 2014",
            "authors": [],
            "year": 2015,
            "venue": "Infect Dis (London, England)",
            "volume": "47",
            "issn": "",
            "pages": "734-738",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "Enterovirus D68\u2010associated community\u2010acquired pneumonia in children living in Milan, Italy",
            "authors": [],
            "year": 2015,
            "venue": "J Clin Virol",
            "volume": "68",
            "issn": "",
            "pages": "94-96",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "First enterovirus D68 (EV\u2010D68) cases detected in hospitalised patients in a tertiary care university hospital in Spain, October 2014",
            "authors": [],
            "year": 2015,
            "venue": "Enferm Infecc Microbiol Clin",
            "volume": "33",
            "issn": "",
            "pages": "585-589",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "Emergence of enterovirus D68 in Denmark, June 2014 to February 2015",
            "authors": [],
            "year": 2015,
            "venue": "Euro Surveill Bull Eur sur les Mal Transm = Eur Commun Dis Bull",
            "volume": "20",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation",
            "authors": [],
            "year": 2015,
            "venue": "Lancet Respir Med",
            "volume": "3",
            "issn": "",
            "pages": "879-887",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "Enterovirus D68: a focused review and clinical highlights from the 2014 U.S. outbreak",
            "authors": [],
            "year": 2015,
            "venue": "Ann Am Thorac Soc",
            "volume": "12",
            "issn": "",
            "pages": "775-781",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "Epidemiology of enterovirus D68 in Ontario",
            "authors": [],
            "year": 2015,
            "venue": "PLoS ONE",
            "volume": "10",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1371/journal.pone.0142841"
                ]
            }
        },
        "BIBREF18": {
            "title": "The emergence of enterovirus D68 in a Dutch University Medical Center and the necessity for routinely screening for respiratory viruses",
            "authors": [],
            "year": 2015,
            "venue": "J Clin Virol",
            "volume": "62",
            "issn": "",
            "pages": "1-5",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "European surveillance for enterovirus D68 during the emerging North\u2010American outbreak in 2014",
            "authors": [],
            "year": 2015,
            "venue": "J Clin Virol",
            "volume": "71",
            "issn": "",
            "pages": "1-9",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "Low\u2010level circulation of enterovirus D68\u2010associated acute respiratory infections, Germany, 2014",
            "authors": [],
            "year": 2015,
            "venue": "Emerg Infect Dis",
            "volume": "21",
            "issn": "",
            "pages": "837-841",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "High frequency of enterovirus D68 in children hospitalised with respiratory illness in Norway, autumn 2014",
            "authors": [],
            "year": 2015,
            "venue": "Influenza Other Respi Viruses",
            "volume": "9",
            "issn": "",
            "pages": "59-63",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF22": {
            "title": "Systematic community\u2010and hospital\u2010based surveillance for enterovirus\u2010D68 in three Canadian provinces, August to December 2014",
            "authors": [],
            "year": 2015,
            "venue": "Eurosurveillance",
            "volume": "20",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.2807/1560-7917.ES.2015.20.43.30047"
                ]
            }
        },
        "BIBREF23": {
            "title": "Enterovirus D68 infection, Chile, Spring 2014",
            "authors": [],
            "year": 2015,
            "venue": "Emerg Infect Dis United States",
            "volume": "21",
            "issn": "",
            "pages": "728-\u2013729",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF24": {
            "title": "Enterovirus D68 and other enterovirus serotypes identified in South African patients with severe acute respiratory illness, 2009\u20132011",
            "authors": [],
            "year": 2017,
            "venue": "Influenza Other Respi Viruses",
            "volume": "11",
            "issn": "",
            "pages": "211-219",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF25": {
            "title": "Respiratory viral coinfections identified by a 10\u2010Plex real\u2010time reverse\u2010transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory illness\u2010South Africa, 2009\u20132010",
            "authors": [],
            "year": 2012,
            "venue": "J Infect Dis",
            "volume": "206",
            "issn": "",
            "pages": "S159-\u2013",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF26": {
            "title": "Rapid and sensitive routine detection of all members of the genus enterovirus in different clinical specimens by real\u2010time PCR",
            "authors": [],
            "year": 2002,
            "venue": "J Clin Microbiol",
            "volume": "40",
            "issn": "",
            "pages": "3666-3670",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF27": {
            "title": "MAFFT multiple sequence alignment software version 7: improvements in performance and usability",
            "authors": [],
            "year": 2013,
            "venue": "Mol Biol Evol",
            "volume": "30",
            "issn": "",
            "pages": "772-780",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF28": {
            "title": "BioEdit: a user\u2010friendly biological sequence alignment editor and analysis program for Windows 95/98/NT",
            "authors": [],
            "year": 1999,
            "venue": "Nucleic Acids Symp Ser",
            "volume": "41",
            "issn": "",
            "pages": "95-\u201398",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF29": {
            "title": "MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0",
            "authors": [],
            "year": 2007,
            "venue": "Mol Biol Evol",
            "volume": "24",
            "issn": "",
            "pages": "1596-1599",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF30": {
            "title": "Phylogeography of circulating populations of human echovirus 30 over 50 years: nucleotide polymorphism and signature of purifying selection in the VP1 capsid protein gene",
            "authors": [],
            "year": 2009,
            "venue": "Infect Genet Evol",
            "volume": "9",
            "issn": "",
            "pages": "699-708",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF31": {
            "title": "Worldwide emergence of multiple clades of enterovirus 68",
            "authors": [],
            "year": 2012,
            "venue": "J Gen Virol",
            "volume": "93",
            "issn": "",
            "pages": "1952-1958",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF32": {
            "title": "Phylogenetic patterns of human coxsackievirus B5 arise from population dynamics between two genogroups and reveal evolutionary factors of molecular adaptation and transmission",
            "authors": [],
            "year": 2013,
            "venue": "J Virol",
            "volume": "87",
            "issn": "",
            "pages": "12249-12259",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF33": {
            "title": "Molecular epidemiology of echoviruses 11 and 30 in Russia: different properties of genotypes within an enterovirus serotype",
            "authors": [],
            "year": 2015,
            "venue": "Infect Genet Evol",
            "volume": "30",
            "issn": "",
            "pages": "244-248",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF34": {
            "title": "An outbreak of aseptic meningitis caused by a distinct lineage of coxsackievirus B5 in China",
            "authors": [],
            "year": 2014,
            "venue": "Int j Infect Dis",
            "volume": "23",
            "issn": "",
            "pages": "101-104",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF35": {
            "title": "Genetic variation of coxsackie virus B5 strains associated with aseptic meningitis in Greece",
            "authors": [],
            "year": 2006,
            "venue": "Clin Microbiol Infect",
            "volume": "12",
            "issn": "",
            "pages": "688-691",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF36": {
            "title": "Severe respiratory illness associated with enterovirus D68\u2014Missouri and Illinois, 2014",
            "authors": [],
            "year": 2014,
            "venue": "Am J Transplant",
            "volume": "63",
            "issn": "",
            "pages": "798-\u2013799",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF37": {
            "title": "Enterovirus D\u201068 infection, prophylaxis, and vaccination in a novel permissive animal model, the cotton rat (Sigmodon hispidus)",
            "authors": [],
            "year": 2016,
            "venue": "PLoS ONE",
            "volume": "11",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF38": {
            "title": "Presence of human non\u2010polio enterovirus and parechovirus genotypes in an Amsterdam hospital in 2007 to 2011 compared to national and international published surveillance data: a comprehensive review",
            "authors": [],
            "year": 2014,
            "venue": "Eurosurveillance",
            "volume": "19",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.2807/1560-7917.ES2014.19.46.20964"
                ]
            }
        }
    }
}